Paradigm Shift for Treatment of Atrial Fibrillation in Heart Failure.
暂无分享,去创建一个
[1] S. Prabhu,et al. Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI) , 2017 .
[2] Dhanunjaya R. Lakkireddy,et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial , 2016, Circulation.
[3] D. Levy,et al. Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. , 2016, Circulation.
[4] Jamil Mayet,et al. A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) , 2014, Circulation. Arrhythmia and electrophysiology.
[5] David O. Martin,et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.
[6] A. Camm,et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .
[7] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.
[8] A. Camm,et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.
[9] J. Brachmann,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. , 2018, The New England journal of medicine.